BT
Bioxcel Therapeutics
BTAI·NASDAQNew Haven CTFounded 2017150 employees
Micro CapbiotechPublicCNS
Platform: IGALMI Agitation
Market Cap
$0.1B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (BTAI)
Loading BTAI stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| BTA-3746 | BTA-3746 | Phase 2 | 1 | C5 | MyelofibrosisBCC | ||
| BTA-1886 | BTA-1886 | Phase 1 | 1 | FXIa | ThymomaHuntington's |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)